Amarin Corp PLC (AMRN)
0.8675
-0.01
(-1.42%)
USD |
NASDAQ |
May 10, 11:09
Amarin Cash from Investing (TTM): 22.81M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 22.81M |
December 31, 2023 | -25.52M |
September 30, 2023 | 17.66M |
June 30, 2023 | 17.76M |
March 31, 2023 | 56.63M |
December 31, 2022 | 175.29M |
September 30, 2022 | 228.12M |
June 30, 2022 | 97.76M |
March 31, 2022 | 75.22M |
December 31, 2021 | 104.10M |
September 30, 2021 | 102.77M |
June 30, 2021 | 197.90M |
March 31, 2021 | 44.79M |
December 31, 2020 | -376.96M |
September 30, 2020 | -401.01M |
June 30, 2020 | -397.97M |
March 31, 2020 | -296.30M |
December 31, 2019 | -2.478M |
September 30, 2019 | -2.119M |
June 30, 2019 | -0.859M |
March 31, 2019 | -0.058M |
December 31, 2018 | -0.058M |
September 30, 2018 | -0.053M |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | -0.012M |
September 30, 2017 | -0.012M |
June 30, 2017 | -0.012M |
March 31, 2017 | -0.012M |
December 31, 2016 | -0.021M |
September 30, 2016 | -0.039M |
June 30, 2016 | -0.049M |
March 31, 2016 | -0.049M |
December 31, 2015 | -0.028M |
September 30, 2015 | -0.01M |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | -0.014M |
September 30, 2013 | -12.64M |
June 30, 2013 | -13.27M |
March 31, 2013 | -14.26M |
December 31, 2012 | -14.34M |
September 30, 2012 | -2.08M |
June 30, 2012 | -3.128M |
March 31, 2012 | -2.14M |
December 31, 2011 | -2.048M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-401.01M
Minimum
Sep 2020
228.12M
Maximum
Sep 2022
-18.12M
Average
20.28M
Median
Cash from Investing (TTM) Benchmarks
Trinity Biotech PLC | 24.76M |
DBV Technologies SA | -0.808M |
Adaptimmune Therapeutics PLC | 176.54M |
Akari Therapeutics PLC | -- |
Biodexa Pharmaceuticals Plc | -0.3289M |